Format

Send to

Choose Destination
Psychopharmacology (Berl). 2008 Nov;200(4):475-86. doi: 10.1007/s00213-008-1225-5. Epub 2008 Sep 2.

Brain mu-opioid receptor binding: relationship to relapse to cocaine use after monitored abstinence.

Author information

1
Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, USA. dgorelic@mail.nih.gov

Abstract

RATIONALE:

Cocaine users have increased regional brain mu-opioid receptor (mOR) binding which correlates with cocaine craving. The relationship of mOR binding to relapse is unknown.

OBJECTIVE:

To evaluate regional brain mOR binding as a predictor of relapse to cocaine use is the objective of the study.

MATERIALS AND METHODS:

Fifteen nontreatment-seeking, adult cocaine users were housed on a closed research ward for 12 weeks of monitored abstinence and then followed for up to 1 year after discharge. Regional brain mOR binding was measured after 1 and 12 weeks using positron emission tomography (PET) with [11C]carfentanil (a selective mOR agonist). Time to first cocaine use (lapse) and to first two consecutive days of cocaine use (relapse) after discharge was based on self-report and urine toxicology.

RESULTS:

A shorter interval before relapse was associated with increased mOR binding in frontal and temporal cortical regions at 1 and 12 weeks of abstinence (Ps < 0.001) and with a lesser decrease in binding between 1 and 12 weeks (Ps < 0.0008). There were significant positive correlations between mOR binding at 12 weeks and percent days of cocaine use during first month after relapse (Ps < 0.002). In multiple linear regression analysis, mOR binding contributed significantly to the prediction of time to relapse (R2= 0.79, P < 0.001), even after accounting for clinical variables.

CONCLUSIONS:

Increased brain mOR binding in frontal and temporal cortical regions is a significant independent predictor of time to relapse to cocaine use, suggesting an important role for the brain endogenous opioid system in cocaine addiction.

PMID:
18762918
PMCID:
PMC2575005
DOI:
10.1007/s00213-008-1225-5
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center